Bernard Malfroy-Camine Net Worth

Bernard Malfroy-Camine biography

Dr. Bernard Malfroy-Camine Ph.D. serves as Independent Director of the Company. He has served as a director since July 2012. He is a scientist-turned-entrepreneur with nearly 30 years of experience in biotechnology and drug discovery. Since May 2013, he has been President and CEO of ViThera Pharmaceuticals, Inc. He has also served as Director, Business Development US Operations at Voisin Consulting, Inc. (also known as Voisin Consulting Life Sciences) since September 2012. Since October 2008, Dr. Malfroy-Camine has also been Founder, President and CEO of MindSet Rx, Inc., a virtual company which is a continuation of Eukarion, Inc., a biotech company he had founded in 1991, and of which he was President and CEO. Dr. Malfroy-Camine has over 80 scientific publications and holds approximately 20 patents. He has a Master’s degree in Mathematics and Physics from Ecole Polytechnique (Paris) and a Ph.D. in Neurobiology from University Paris VI.

What is the salary of Bernard Camine?

As the Independent Director of AB Active ETFs Inc, the total compensation of Bernard Camine at AB Active ETFs Inc is $55,986. There are 6 executives at AB Active ETFs Inc getting paid more, with Stephen From having the highest compensation of $601,340.

How old is Bernard Camine?

Bernard Camine is 67, he's been the Independent Director of AB Active ETFs Inc since 2012. There are 1 older and 8 younger executives at AB Active ETFs Inc. The oldest executive at AB Active ETFs Inc is Morton Goldberg, 82, who is the Independent Director.

What's Bernard Camine's mailing address?

Bernard's mailing address filed with the SEC is C/O EYEGATE PHARMACEUTICALS, INC., 271 WAVERLEY OAKS ROAD, SUITE 108, WALTHAM, MA, 02452.

Insiders trading at AB Active ETFs Inc

Over the last 10 years, insiders at AB Active ETFs Inc have traded over $15,523,641 worth of AB Active ETFs Inc stock and bought 17,254,349 units worth $18,625,708 . The most active insiders traders include Capital, Llc Armistice Capi..., Peter Greenleaf, and (Innoven Partenaires S.A.) .... On average, AB Active ETFs Inc executives and independent directors trade stock every 60 days with the average trade being worth of $19,985,138. The most recent stock trade was executed by Capital, Llc Armistice Capi... on 30 July 2021, trading 260,963 units of EYEG stock currently worth $647,188.

What does AB Active ETFs Inc do?

AB Active ETFs Inc executives and stock owners

AB Active ETFs Inc executives and other stock owners filed with the SEC include:

• Stephen From,
  President, Chief Executive Officer, Director
• Michael Manzo,
  Vice President - Engineering
• Sarah Romano,
  Chief Financial Officer
• Paul Chaney,
  Independent Chairman of the Board
• Praveen Tyle,
  Independent Director
• Thomas Hancock,
  Independent Director
• Bernard Malfroy-Camine,
  Independent Director
• Morton Goldberg,
  Independent Director
• Keith Maher,
  Director
• Steven Boyd,
  Director
• Brenda Mann,
  VP of Research & Development
• Michael Garanzini,
  Chief Commercial Officer
• Peter Greenleaf,
  Director
• Barbara Wirostko,
  Chief Medical Officer
• (Innoven Partenaires S.A.) ...,
  10% owner
• Private Equity Natixis,
  10% owner
• Thomas Balland,
  Director
• Ventech B Fcpr,
  10% owner
• Capital Ii Ventech,
  10% owner
• Mounia Chaoui,
  Director
• Ryan Randall Brenneman,
  Chief Financial Officer
• Franz Obermayr,
  Acting CEO
• Kenneth L Gayron,
  Director
• Aron Shapiro,
  Director
• Brian M. Strem,
  President and CEO